This career development award project will compare the effectiveness of pharmacological therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia in preventing long-term disease progression; and develop and validate predictive models using demographic, clinical, and laboratory data available at the time of diagnosis to identify patients at increased risk of long-term disease progression.
Long-term effectiveness of BPH/LUTS pharmacological therapies and using machine learning based predictive analytics to tailor treatment.
Investigator: Langston, Marvin
Funder: National Institute of Diabetes and Digestive and Kidney Diseases